Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
Monoclonal antibodies are highly effective medications, which made a breakthrough in medicine. Taking into consideration the properties of monoclonal antibodies safety plays a key role in “risk-benefit” assessment. For monoclonal antibodies this remains studied insufficiently. The article presents a...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
Izdatelstvo OKI
2019-10-01
|
| シリーズ: | Качественная клиническая практика |
| 主題: | |
| オンライン･アクセス: | https://www.clinvest.ru/jour/article/view/454 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|